The U.S. Food and Drug Administration (FDA) has approved revumenib, a pioneering drug for relapsed or refractory acute ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii), a novel therapy for ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...

Researchers from Cambridge University Hospitals, in collaboration with the NHS Health Research Authority, have launched the ...

The FDA has approved Caris Life Sciences’ MI Cancer Seek, a pioneering diagnostic test combining Whole Exome and Whole ...

IMUNON’s Phase 2 OVATION 2 study shows promising results for its immunotherapy, IMNN-001, in advanced ovarian cancer. Combined with standard chemotherapy, IMNN-001 improved overall survival by 35% and ...

This website is organized and funded by Health and Pharma and it is not intended for a specific location or country; it represents a fully international brand. Additionally, it contains promotional ...